Isla Leslie

2.9k total citations
15 papers, 246 citations indexed

About

Isla Leslie is a scholar working on Oncology, Genetics and Biomedical Engineering. According to data from OpenAlex, Isla Leslie has authored 15 papers receiving a total of 246 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 4 papers in Genetics and 4 papers in Biomedical Engineering. Recurrent topics in Isla Leslie's work include CAR-T cell therapy research (4 papers), Virus-based gene therapy research (3 papers) and Cancer Research and Treatments (3 papers). Isla Leslie is often cited by papers focused on CAR-T cell therapy research (4 papers), Virus-based gene therapy research (3 papers) and Cancer Research and Treatments (3 papers). Isla Leslie collaborates with scholars based in United Kingdom, United States and Spain. Isla Leslie's co-authors include G. Bentley, Richard Mott, Amy Taylor, David M. Bannerman, Jonathan Flint, Guo‐Jen Huang, Stephen B. McHugh, Marcus R. Munafò, David A. Fischer and Kevin J. Harrington and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer Research.

In The Last Decade

Isla Leslie

13 papers receiving 231 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Isla Leslie United Kingdom	6	84	72	52	49	48	15	246
Haley E. Titus United States	8	75 0.9×	45 0.6×	27 0.5×	13 0.3×	12 0.3×	8	368
Tsen‐Hsuan Lin United States	11	16 0.2×	47 0.7×	21 0.4×	31 0.6×	7 0.1×	17	372
Lucy Zhao China	11	26 0.3×	32 0.4×	40 0.8×	12 0.2×	15 0.3×	17	360
Iris Dekker Netherlands	14	49 0.6×	37 0.5×	7 0.1×	13 0.3×	71 1.5×	21	566
Cecilia Condello Italy	6	60 0.7×	21 0.3×	33 0.6×	5 0.1×	32 0.7×	6	407
Michelle M. Inserra United States	9	63 0.8×	17 0.2×	87 1.7×	11 0.2×	11 0.2×	12	372
Takao Hase Japan	7	49 0.6×	20 0.3×	117 2.3×	27 0.6×	10 0.2×	7	345
Brian Rothstein United States	6	96 1.1×	7 0.1×	58 1.1×	24 0.5×	9 0.2×	14	375
Nimshitha Pavathuparambil Abdul Manaph Qatar	10	48 0.6×	49 0.7×	89 1.7×	4 0.1×	9 0.2×	17	311
Joseph L. Hegarty United States	7	31 0.4×	21 0.3×	54 1.0×	4 0.1×	43 0.9×	9	508

Countries citing papers authored by Isla Leslie

Since Specialization

Citations

This map shows the geographic impact of Isla Leslie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Isla Leslie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Isla Leslie more than expected).

Fields of papers citing papers by Isla Leslie

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Isla Leslie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Isla Leslie. The network helps show where Isla Leslie may publish in the future.

Co-authorship network of co-authors of Isla Leslie

This figure shows the co-authorship network connecting the top 25 collaborators of Isla Leslie. A scholar is included among the top collaborators of Isla Leslie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Isla Leslie. Isla Leslie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Bommareddy, Praveen K., Alireza Kalbasi, Kevin J. Harrington, et al.. (2024). Abstract 2467: Enhanced CD8+T-cell infiltration, PD-L1 expression, and T-cell repertoire expansion in patients with metastatic uveal melanoma responding to treatment with RP2 alone or in combination with nivolumab. Cancer Research. 84(6_Supplement). 2467–2467. 1 indexed citations

Sacco, Joseph J., Kevin J. Harrington, Anna Olsson‐Brown, et al.. (2024). Safety, efficacy, and biomarker results from an open-label, multicenter, phase 1 study of RP2 alone or combined with nivolumab in a cohort of patients with uveal melanoma.. Journal of Clinical Oncology. 42(16_suppl). 9511–9511. 6 indexed citations

Sacco, Joseph J., Kevin J. Harrington, Anna Olsson‐Brown, et al.. (2023). Preliminary safety and efficacy results from an open-label, multicenter, phase 1 study of RP2 as a single agent and in combination with nivolumab in a cohort of patients with uveal melanoma.. Journal of Clinical Oncology. 41(16_suppl). 9527–9527. 4 indexed citations

Harrington, Kevin J., Joseph J. Sacco, Anna Olsson‐Brown, et al.. (2022). A phase 1 trial of RP2, a first-in-class, enhanced potency oncolytic HSV expressing an anti-CTLA-4 antibody as a single agent and combined with nivolumab in patients with advanced solid tumors.. Journal of Clinical Oncology. 40(16_suppl). TPS2704–TPS2704. 3 indexed citations

Nenclares, Pablo, Isla Leslie, Kee H. Wong, et al.. (2021). On-treatment immune prognostic score for patients with relapsed and/or metastatic head and neck squamous cell carcinoma treated with immunotherapy. Journal for ImmunoTherapy of Cancer. 9(6). e002718–e002718. 29 indexed citations

Middleton, Mark R., Joseph J. Sacco, Kevin J. Harrington, et al.. (2021). 507 A phase 1 clinical trial of RP2, an enhanced potency oncolytic HSV expressing an anti-CTLA-4 antibody, as a single agent and combined with nivolumab in patients with advanced solid tumors. SHILAP Revista de lepidopterología. A539–A539. 1 indexed citations

Leslie, Isla, et al.. (2021). Collaborating with low- and middle-income countries: Experience from two of the United Kingdom’s comprehensive cancer centers.. Journal of Clinical Oncology. 39(15_suppl). e23014–e23014.

Boos, Laura, Isla Leslie, & James Larkin. (2020). Metastatic melanoma: therapeutic agents in preclinical and early clinical development. Expert Opinion on Investigational Drugs. 29(7). 739–753. 3 indexed citations

Comito, Francesca, Isla Leslie, Laura Boos, et al.. (2020). Oligoprogression After Checkpoint Inhibition in Metastatic Melanoma Treated With Locoregional Therapy: A Single-center Retrospective Analysis. Journal of Immunotherapy. 43(8). 250–255. 8 indexed citations

10.

Leslie, Isla, Laura Boos, James Larkin, & Lisa Pickering. (2020). Avelumab and axitinib in the treatment of renal cell carcinoma: safety and efficacy. Expert Review of Anticancer Therapy. 20(5). 343–354. 3 indexed citations

11.

Coakley, Maria, et al.. (2019). Prevention of Everolimus-related Stomatitis: a Retrospective and Prospective Study. Clinical Oncology. 31(7). e107–e108. 1 indexed citations

12.

Leslie, Isla, et al.. (2017). Speeding up laboratory test reporting in Medical Emergency and Cardiac Arrest calls: a quality improvement project. BMJ Quality Improvement Reports. 6(1). u213103.w5207–u213103.w5207. 2 indexed citations

13.

Leslie, Isla, Guo‐Jen Huang, Stephen B. McHugh, et al.. (2013). Ablating Adult Neurogenesis in the Rat Has No Effect on Spatial Processing: Evidence from a Novel Pharmacogenetic Model. PLoS Genetics. 9(9). e1003718–e1003718. 98 indexed citations

14.

Bentley, G., Isla Leslie, & David A. Fischer. (1981). Effect of aspirin treatment on chondromalacia patellae.. Annals of the Rheumatic Diseases. 40(1). 37–41. 15 indexed citations

15.

Leslie, Isla & G. Bentley. (1978). Arthroscopy in the diagnosis of chondromalacia patellae.. Annals of the Rheumatic Diseases. 37(6). 540–547. 72 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact